U.S. Interactive Media and Services Stock News

L1 Capital International Fund has recently exited its long-term position in Eagle Materials Inc., citing concerns that a softer U.S. housing cycle and housing affordability pressures could weigh on demand and pricing for key products such as wallboard and cement. This complete divestment by a previously significant shareholder highlights how worries about new housing starts and construction activity are influencing institutional views on building materials exposure. We’ll now examine how L1...

ADMA Biologics recently reported quarterly results that beat revenue expectations, raised its 2025 and 2026 earnings guidance, and highlighted an FDA‑approved manufacturing process expected to lift yields by around 20% and support long‑term margin expansion. This combination of stronger near‑term performance and structurally improved manufacturing efficiency underpins management’s projection that earnings per share could be around four times higher by 2030. Next, we’ll examine how the new...

Sabine Royalty Trust recently reported December 2025 preliminary production of about 28,904 barrels of oil and 796,698 Mcf of gas, alongside a monthly cash distribution of US$0.196670 per unit payable on December 29, 2025, to holders of record on December 15, 2025. This payout represents the fourth straight monthly reduction and the lowest distribution since 2021, underscoring how weaker production has compressed income for unitholders. Against this backdrop of lower production and a sharply...

Earlier this year, QuidelOrtho reported third-quarter results that exceeded analyst expectations on both revenue and earnings and raised its full-year guidance, despite posting the slowest revenue growth among major medical device and diagnostics peers. The combination of an earnings and revenue beat with a guidance increase, even amid relatively modest growth, highlights how execution and outlook can matter as much as headline growth rates for a diagnostics company formed from the Quidel...

SL Green Realty (SLG) just reported 2.3 million square feet of Manhattan office leases signed in 2025, plus a 1.2 million square foot pipeline, putting its same store occupancy target of 93% within sight. See our latest analysis for SL Green Realty. Even with this leasing momentum and a latest share price of $44.64, the 7 day share price return of 7.49% comes after a much steeper 90 day share price decline of 32.02%. At the same time, the 3 year total shareholder return of 66.77% shows that...

Kymera Therapeutics recently reported positive Phase 1b data for KT-621, its first-in-class oral STAT6 degrader in moderate to severe atopic dermatitis, and subsequently secured FDA Fast Track designation for KT-621, while also completing an upsized US$602.0 million follow-on equity offering. Together, the encouraging KT-621 efficacy and safety signals, regulatory acceleration via Fast Track, and strengthened cash position could meaningfully reshape expectations for Kymera’s Type 2...

Analyst reaction to Arch Capital Group (ACGL) after its mixed Q3 results is shaping the conversation, with softer written premium growth and cooling mortgage and reinsurance demand now front and center for investors. See our latest analysis for Arch Capital Group. At around $93.92 per share, Arch’s recent 7.48% 3 month share price return contrasts with a more modest 2.82% 1 year total shareholder return. This hints that near term optimism is building even as conference appearances and mixed...

Key Insights Scinai Immunotherapeutics to hold its Annual General Meeting on 22nd of December Total pay for CEO Amir...

Hess Midstream (HESM) just gave investors a two part update, providing a fresh 2026 earnings and volumes outlook along with a reshaped board that tightens Chevron’s grip on the partnership’s governance. See our latest analysis for Hess Midstream. Those 2026 targets and the tighter Chevron link come after a choppy stretch, with a 4.5% 1 month share price return but a weak 90 day slide. A 5 year total shareholder return above 140% shows the long term story is still intact, and momentum...

Tyra Biosciences (TYRA) just reshuffled its leadership bench, bringing in regulatory veteran Heather Faulds as Chief Regulatory Officer and commercial operator Bhavesh Ashar as Chief Operating Officer to help steer its advancing clinical pipeline. See our latest analysis for Tyra Biosciences. Those hires land as Tyra’s share price has climbed to $22.63, with a 30 day share price return of 43.87 percent and a three year total shareholder return of 222.36 percent, which signals strong and...

Vontier (VNT) just drew fresh attention after its Gilbarco Veeder-Root unit rolled out the Konect 400 kW All in One EV Charger, combining ultra fast charging with integrated payments for fuel and convenience retailers. See our latest analysis for Vontier. The launch of Konect lands as Vontier’s share price sits around $37.10, with a modest year to date share price return and a standout three year total shareholder return above 100 percent. This suggests longer term momentum may remain intact...

In the past quarter, Okta reported third-quarter revenue of US$742 million and net income of US$43 million, with earnings rising versus a year earlier and full-year fiscal 2026 revenue now guided to about US$2.91 billion. Despite concurrent headlines about sophisticated phishing campaigns targeting Okta users, investors appear focused on the company’s improving profitability and cash-generation profile as it matures operationally. We’ll now examine how Okta’s stronger profitability and...

Recently, viagogo announced a partnership with Booking.com that lets fans booking tickets add nearby accommodation, flights, car rentals, and local attractions in a single flow, tapping into the growing “gig-tripping” trend of traveling specifically for events. Alongside this, Booking Holdings’ brands such as Booking.com and Agoda are leaning further into AI-powered trip planning and multi-vertical offerings, reinforcing their push toward a more integrated, experience-led travel...

Vera Therapeutics (VERA) just wrapped up a sizeable follow on stock offering, raising over $260 million ahead of a key FDA decision on its lead drug candidate, atacicept, and investors are paying attention. See our latest analysis for Vera Therapeutics. The follow on deal has reset expectations in a big way, with the 30 day share price return of roughly 76 percent and 3 month share price return just over 100 percent showing that momentum is clearly building rather than fading as markets...

First Industrial Realty Trust (FR) is back in the spotlight after activist investor Land and Buildings went public with criticism of the REIT’s valuation, urging asset sales and even a strategic alternatives review. See our latest analysis for First Industrial Realty Trust. The activist noise is landing on a stock that already had the wind at its back, with a roughly 18 percent year to date share price return and a 5 year total shareholder return north of 60 percent, suggesting momentum is...

In recent months, Procter & Gamble has reported softer category demand, heavier discounting, and intensifying competition in North America and Europe, even as it reaffirmed full-year guidance and continued restructuring and innovation efforts. At the same time, P&G is leaning on its 68-year record of annual dividend increases and experimenting with micro-episode content like “The Golden Pear Affair” to reinforce brand loyalty and reach younger consumers. We’ll now examine how rising...

On December 4, 2025, TriMas Corporation announced that its Board appointed long-time company veteran Paul Swart as Chief Financial Officer and principal accounting officer, effective December 15, 2025, succeeding interim CFO and current board member Teresa Finley. Investors may view Swart’s return as important because he combines two decades of prior TriMas experience with recent external leadership overseeing acquisitions, financial transformation, and integration. We’ll now examine how...

OSI Systems (OSIS) has been on a strong multi year run, yet the stock slipped about 2% in the latest session and is down roughly 5% over the past month. See our latest analysis for OSI Systems. Despite the recent 1 month share price pullback, OSI Systems is still trading at about $259.44 and its year to date share price return points to momentum that has been strong rather than fading, backed by multi year total shareholder returns that remain exceptional. If OSI Systems has you rethinking...

CenterPoint Energy (CNP) is back on investors radar after a fresh analyst upgrade, strong quarterly numbers, and a steady dividend track record converged with buzz around its role in Palantir Chain Reaction. See our latest analysis for CenterPoint Energy. Those catalysts are arriving after a solid run, with the share price at $37.84 and a strong year to date share price return of around 20 percent. Multi year total shareholder returns suggest steady, compounding momentum rather than a sudden...

Grindr (GRND) is back in the spotlight after law firm Johnson Fistel launched an investigation into whether the Board breached fiduciary duties when it ended talks with the company’s controlling stockholder. See our latest analysis for Grindr. That backdrop helps explain why sentiment has cooled, with a 90 day share price return of minus 15.58 percent and a year to date share price return of minus 26.02 percent. Even so, the three year total shareholder return remains strongly positive at...

Kuber Resources Corporation recently entered a non-binding cooperation framework agreement with Yuli Listing Operation Co. to explore up to US$30 million in potential financing for acquiring intellectual property assets such as patents and trademarks. By keeping the framework non-binding and subject to further negotiation and board approval, Kuber preserves flexibility and control over how it funds future IP-driven expansion. We’ll now examine how this flexible IP-focused financing...

AI adoption in Latin America's payments and e-commerce sectors is expanding rapidly, driven by fintech hubs in Brazil, Mexico, and Colombia. These countries are leveraging strong fintech ecosystems and favorable regulations to enhance digital payment solutions. Despite this momentum, challenges such as talent shortages, high implementation costs, and inconsistent regulatory enforcement hinder wider AI scalability and adoption, particularly in smaller economies. As regional governance evolves,...

Earlier this month, DXC Technology launched AdvisoryX, a global advisory and consulting group that combines strategy, operations and engineering expertise to help enterprises tackle complex AI, technology and business transformation challenges across the full AI lifecycle. By pairing its new AdvisoryX practice with research showing most organizations struggle to build a clear AI business case and scale deployments, DXC is positioning itself as a problem‑solver for the execution gap between...

Why Molina Healthcare Is Back on Investors' Radar Molina Healthcare (MOH) has quietly staged a comeback, with shares up about 9% over the past week and more than 22% this month, even as the past 3 months remain slightly negative. See our latest analysis for Molina Healthcare. That sharp 22.5% 1 month share price return looks more like a relief rally than a full turnaround, given the 41.3% year to date share price decline and similarly weak longer term total shareholder returns. If Molina’s...